Knowledge, perception and practice of pharmacovigilance among community pharmacists in South India
Pharmacovigilance has not progressed well in India and the concept is still in its infancy. India rates below 1% in pharmacovigilance as against the world rate of 5%.
Objectives: The aim of our study was to evaluate the knowledge, perception and practice of pharmacovigilance among registered community pharmacists in Hyderabad, India.
Methods: This was a prospective study to find out the knowledge, perception and practice of adverse drug reaction reporting among community pharmacists. It was conducted by a face to face questionnaire and the convenience factor of the pharmacist was taken into consideration.
Results: From the 650 questionnaire administered to community pharmacists, 347 (53.3%) were returned completely filled questionnaires. A number of 120 (34.6%) pharmacists could define the term ‘pharmacovigilance’ to an acceptable extent and 119 (34.3%) knew about the National Pharmacovigilance Programme in India. 96 (27.7%) had good knowledge, 36(10.4%) had fair knowledge and 215(61.9%) had poor knowledge about pharmacovigilance. We have found that 196 (56.5%) had good perception, 94(27.1%) had fair perception and 57(16.4%) had poor perception. Only 41(11.8%) pharmacists ever reported an ADR and the other never reported ADR. The majority of pharmacists 223(64.3%) felt that the AE is very simple and non-serious and hence did not report. Pharmacists have poor knowledge, good perception and negligibly low reporting rates.Conclusions: Incorporation of ADR reporting concepts in education curriculum, training of pharmacists and voluntary participation of pharmacists in ADR reporting is very crucial in achieving the safety goals and safeguarding public health.
2. World Health Organization. Safety of Medicines. A guide to detecting and reporting adverse drug reactions. Why health professionals need to take action. Geneva World Health Organization. 2002.
3. www.fda.gov/consumer/updates/drugterms041108.html (Accessed on Dec. 2011)
4. Vallano A, Cereza G, Pedròs C, Agustí A, Danés I, Aguilera C, Arnau JM.. Obstacles and solutions for spontaneous reporting of adverse drug reactions in the hospital. Br J Clin Pharmacol. 2005;60(6):653-658.
5. www.Pharmacovigilance.co.in (Accessed on Dec. 2011)
6. The Learning Centre. Continuing pharmacy education; fall 1999. Canada: University of British Columbia; 1999. Pharmacists are number one.
7. Bäckström M, Mjörndal T, Dahlqvist R, Nordkvist-Olsson T. Attitudes of reporting adverse drug reactions in Northern Sweden. Eur J Clin Pharmacol. 2000;56(9-10):729-732.
8. Amrita P, Roomi M.T, Scenario of Pharmacovigilance and ADR Reporting among Pharmacists in Delhi, Indian Journal of Pharmacy Practice. 2011;4(4):29-38.
9. Oreagba IA, Ogunleye OJ Olayemi SO. The knowledge, perceptions and practice of Pharmacovigilance amongst community pharmacists in Lagos state, south west Nigeria. Pharmacoepidemiol Drug Saf. 2011;20(1):30-35.
10. Green CF, Mottram DR, Raval D, Proudlove C, Randall C. Community pharmacists' attitude to adverse drug reaction reporting. Int J Pharm Pract,. 1999;7(1):92-99.
11. Joseph O Fadare, Okezie O Enwere, AO Afolabi, BAZ Chedi , Musa A. Knowledge, Attitude and Practice of Adverse Drug Reaction Reporting among Healthcare Workers in a Tertiary Centre in Northern Nigeria. Trop J Pharm Res. 2011;10(3):235-242.
12. Ramesh Madhan, Parthasarathi G. Attitudes and perceptions of medical practitioners-Adverse drug reactions reporting. Asian Journal of pharmaceutical and Clinical Research, 2009; 2(2):184-189.
13. Sweis D, Wong IC. A survey on factors that could affect adverse drug reaction reporting according to hospital pharmacists in Great Britain. Drug Saf. 2000;23(2):165-172.
14. Pankaj Gupta, Aaditya Udupa. Adverse Drug Reaction Reporting and Pharmacovigilance: Knowledge, Attitudes and Perceptions amongst Resident Doctors. J Pharm Sci Res, 2011; 3(2):1064-1069.
15. Eland IA, Belton KJ, van Grootheest AC, Meiners AP, Rawlins MD, Stricker BH. Attitudinal survey of voluntary reporting of adverse drug reactions. Br J Clin Pharmacol. 1999;48(4):623-627.
16. Gavaza P, Brown CM, Lawson KA, Rascati KL, Wilson JP, Steinhardt M. Influence of attitudes on pharmacists' intention to report serious adverse drug events to the Food and Drug Administration. Br J Clin Pharmacol. 2011;72(1):143-152.
The authors hereby transfer, assign, or otherwise convey to Pharmacy Practice: (1) the right to grant permission to republish or reprint the stated material, in whole or in part, without a fee; (2) the right to print pr epublish copies for free distribution or sale; and (3) the right to republish the stated material in any format (electronic or printed). In addition, the undersigned affirms that the article described above has not previously been published, in whole or part, is not subject to copyright or other rights except by the author(s), and has not been submitted for publication elsewhere, except as communicated in writing to Pharmacy Practice with this document.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY-NC-ND) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
Author Self-Archiving Policy
Pharmacy Practice permits and encourages authors to post and archive the final pdf of the articles submitted to the journal on personal websites or institutional repositories after publication, while providing bibliographic details that credit its publication in this journal.